All In MedTech

Device Trial Radar · NCT05117840

Screening for High Frequency Malignant Disease

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

12,000

Planned (sponsor's estimate)

Start

Jan 13, 2022

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Guardant Health, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 11, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 50 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization. The primary objective of the study is to evaluate the sensitivity and specificity of a blood-based GuardantLUNAR-2 test to detect high frequency cancer in screen-relevant populations.

Conditions

  • Lung Cancer

Interventions

  • Low-dose CT scanDevice

    Standard of care screening for individuals at high-risk of lung cancer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance characteristics of Guardant LUNAR-2 testTime frame: 36 months

Locations

143 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Alabama Birmingham Lung Health Center

    Birmingham, Alabama

142 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.